Intnl. Biotechnology - Portfolio Update

International Biotechnology Trust

02/02/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230202:nRSB6461Oa&default-theme=true

RNS Number : 6461O  Intl. Biotechnology Trust PLC  02 February 2023

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

("IBT" or the "Company")

 

Portfolio Update as at 1 February 2023

 

The Company notes that there has been a material adjustment to the valuation
of an investment from the unquoted portfolio managed by SV Health Managers LLP
in which the Company is invested.

The net asset value of the Company will therefore increase by £2.9m ($3.6m)
which corresponds to 7p per share uplift and will be incorporated into today's
unaudited net asset value (calculated on the AIC basis

For further information contact:

 

 

Company Secretary - Link Company Matters

 

Indu Shastri       +44 (0)7936 045789

 

LEI: 213800N1QUJ744P76D11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PFUBLGDDSUGDGXB